Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 17/20 | 0.50 |
| ▸ | ATP4B | P51164 | 17/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8993812 | 0.81 | ATP4A (0.48) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL8993822 | 0.81 | ATP4A (0.48) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL8650286 | 0.81 | ATP4A (0.62) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL9297889 | 0.78 | ATP4A (0.45) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL9298157 | 0.75 | ATP4A (0.48) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL9292424 | 0.75 | ATP4A (0.44) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL8649873 | 0.75 | ATP4A (0.60) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL9298192 | 0.73 | ATP4A (0.43) | ATP4AATP4BNPC1MAPTRAB9A | |
| SCHEMBL4109611 | 0.68 | ATP4A (1.00) | ATP4AATP4BNPC1MAPTRAB9A | |
| Bromide SCHEMBL826017 | 0.67 | ATP4A (1.00) | ATP4AATP4BNPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0545376-A1 | Guanidino thiazoles and their use as H2-receptor antagonist | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-09 | — | — | EP | disclosed |